Clinical efficacy of surgical treatment of refractory hyperthyroidism in 56 patients
10.3760/cma.j.cn341190-20211119-01297
- VernacularTitle:手术治疗难治性甲状腺功能亢进症56例疗效分析
- Author:
Lihong LI
1
;
Zhongjun JIANG
;
Zheng BAO
;
Nie HU
;
Nian YI
;
Li WANG
;
Ge XU
Author Information
1. 南华大学附属南华医院乳甲外科，衡阳 421200
- Keywords:
Hyperthyroidism;
Thyrotoxicosis;
Endoscopy;
Surgical procedures, operative;
Operative time;
Blood loss,surgical;
Parathyroid hormone;
Postoperative complicat
- From:
Chinese Journal of Primary Medicine and Pharmacy
2023;30(5):709-713
- CountryChina
- Language:Chinese
-
Abstract:
Methods:The clinical data and follow-up results of 56 patients with refractory hyperthyroidism who underwent laparoscopy or open surgery in Affiliated Nanhua Hospital of University of South China from January 2019 to August 2020 were retrospectively analyzed.Results:Among the 56 patients, there were 6 men and 50 women. Thirty-six (64.3%) patients underwent endoscopic surgery and twenty (35.7%) patients underwent open surgery. The operation time was (132.0 ± 32.0) minutes. Intraoperative blood loss was (32.4 ± 27.8) mL. Postoperative parathyroid hormone level was (27.8 ± 18.3) ng/L. Forty-nine (87.5%) patients showed benign pathology results after surgery. After surgery, 14 (25.0%) patients had hypothyroidism, including 7 (12.5%) patients with hyperthyroidism combined with thyroid cancer. There were no patients with permanent hypothyroidism or recurrent laryngeal nerve paralysis. All patients had a good prognosis and satisfactory surgical results.Conclusion:With the update of preoperative preparation methods for hyperthyroidism, the increasing maturity of thyroid surgery technology, and the use of new energy instruments and technologies, surgical treatment is undoubtedly a good treatment method for patients with refractory hyperthyroidism or a suspected malignant tumor.Objevtives:To investigate the indications and clinical efficacy of surgical treatment in patients with refractory hyperthyroidism.
